ITC Issues Initial Determination on Kaneka CoQ10 Patent Infringement Case

The ITC issued its Initial determination on its investigation into the Coenzyme Q10 manufacturers and their distributors in China, Japan and the United States.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Pasadena, TX (PRWEB) October 15, 2012

The United States International Trade Commission, Washington D.C. (ITC) issued its Initial determination on its investigation (case no. 337-TA-2822) into the Coenzyme Q10 manufacturers and their distributors in China, Japan and the United States.

Kaneka North America LLC (KNA) announced today that on September 27, 2012, the Administrative Law Judge (ALJ) in the U.S. International Trade Commission (ITC) issued the Initial Determination on the ITC’s investigation into alleged violation of 19 USC §1337 by Zhejiang Medicine Co. Ltd., ZMC-USA, LLC, Xiamen Kingdomway Group Company, Pacific Rainbow International, Inc, Mitsubishi Gas Chemical Company, Inc., Maypro Industries, Inc., and Shenzhou Biology & Technology Co., Ltd.

As a result, the ALJ initially determined that Kaneka’s US patent No. 7,910,340 (‘340 patent) was valid, but the evidence was insufficient to find ’ infringement of the ‘340 patent by Respondents. Kaneka strongly disagreed with the initial determination and filed a petition for its review on October 10, 2012. The ITC’s final determination will be concluded by January 28, 2013.


Contact

  • Kazuhiko Fujii
    Kaneka North America LLC
    281-291-4424
    Email